Full Year 2024 Nufarm Ltd Earnings Call Transcript
Key Points
- Nufarm Ltd (ASX:NUF) achieved a 30% reduction in net working capital, significantly lowering net debt by 25% to $635 million.
- The company successfully launched new products, with new product introductions contributing to more than 15% of revenues.
- Nufarm Ltd expanded its omega-3 sales, reaching a target of $50 million, and entered an exclusive license for Yield10’s omega-3 camelina technology.
- The company reported strong demand for its products in Asia, achieving growth in EBITDA and expanding 2,4-D capacity at Laverton.
- Nufarm Ltd is targeting $50 million in annualized savings in overhead costs by the end of financial year 2025, aiming to operate more efficiently.
- Underlying EBITDA was 29% below the prior year, and underlying EBIT was 57% below, indicating significant earnings pressure.
- The company reported a statutory net profit loss of $6 billion, impacted by idle plant costs and restructuring expenses.
- Price competition in North America led to a 49% decline in underlying EBITDA, negatively affecting margins.
- Licensing revenue decreased, and the company anticipates further declines due to changes in BP arrangements.
- Nufarm Ltd decided not to issue a final dividend for financial year 2024, reflecting financial challenges.
Thank you for standing by, and welcome to the Nufarm Limited FY â24 Results Call. All participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. (Operator Instructions) I would now like to hand the conference over to Mr. Greg Hunt, CEO. Please go ahead.
Thank you, Harmony, and good morning, everyone. Welcome to Nufarm's financial year â24 results presentation. I'll just take a minute to draw your attention to the disclaimer on Slide 2 and in particular, the statement relating to forward-looking statements. Financial year 2024 was a tough one for the crop protection industry.
Despite the challenges, Nufarm continued to make good progress with our innovation and growth strategies. EBITDA was at the midpoint of the revised guidance that we gave on August 15. We had an outstanding result on networking capital with a 30% reduction on the prior year. This had a similar impact on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
